ARCHIVES

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

First Chop Awards Made, 17 Others In Negotiation For NCI Program To Upgrade Community Cancer Care

October 24, 1980

NIDA Supports Phase III Trial of Anti-Tobacco Vaccine

November 6, 2009

Adjuvant BC Therapy Is Topic Of NIH Consensus Conference.

January 28, 2000

In Brief: Wittes To Return To NCI As Chief Of Medicine Branch; Owens Heads Cancer Research Coalition

June 8, 1990

Agencies Announce Plans To Monitor Gene Therapy Trials.

March 10, 2000

News Organizations Protest invitation-Only Press Conferences, Exclusion of Reporters

May 20, 1994